Tags

Type your tag names separated by a space and hit enter

Brimonidine gel (Mirvaso) for rosacea.
Med Lett Drugs Ther. 2013 Oct 14; 55(1427):82-3.ML

Links

Publisher Full Text

MeSH

Adrenergic alpha-2 Receptor AgonistsBrimonidine TartrateDrug ApprovalGelsHumansQuinoxalinesRandomized Controlled Trials as TopicRosaceaTreatment OutcomeUnited StatesUnited States Food and Drug Administration

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24129112

Citation

"Brimonidine Gel (Mirvaso) for Rosacea." The Medical Letter On Drugs and Therapeutics, vol. 55, no. 1427, 2013, pp. 82-3.
Brimonidine gel (Mirvaso) for rosacea. Med Lett Drugs Ther. 2013;55(1427):82-3.
(2013). Brimonidine gel (Mirvaso) for rosacea. The Medical Letter On Drugs and Therapeutics, 55(1427), 82-3.
Brimonidine Gel (Mirvaso) for Rosacea. Med Lett Drugs Ther. 2013 Oct 14;55(1427):82-3. PubMed PMID: 24129112.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Brimonidine gel (Mirvaso) for rosacea. PY - 2013/10/17/entrez PY - 2013/10/17/pubmed PY - 2013/12/24/medline SP - 82 EP - 3 JF - The Medical letter on drugs and therapeutics JO - Med Lett Drugs Ther VL - 55 IS - 1427 SN - 1523-2859 UR - https://www.unboundmedicine.com/medline/citation/24129112/Brimonidine_gel__Mirvaso__for_rosacea_ L2 - http://www.medicalletter.org/scripts/articlefind.cgi?issue=1427&page=82 DB - PRIME DP - Unbound Medicine ER -